Axcan Pharmaceuticals (AXP-T) Stock Predictions - Stockchase
WATCH LIST
9
Axcan Pharmaceuticals (AXP-T)

ON STOCKCHASE SINCE Dec 2000

biotechnology/pharmaceutical

Axcan Pharmaceuticals

AXP-T

0 watching          
Join the Discussion

Axcan Pharmaceuticals (AXP-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about AXP-T



  • All
  • Filtered
Signal Opinion Expert
TOP PICK
Part pharmaceutical and part drug development. Very profitable. Strong balance sheet and lots of cash flow. Generates about US$1.50 free cash flow every year. In a very stable gastro-intestinal market. They're also in-licence some drugs which gives them some pretty good upside. Trading at about US$14 with $1 a share free cash on the balance sheet.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Part pharmaceutical and part drug development. Very profitable. Strong balance sheet and lots of cash flow. Generates about US$1.50 free cash flow every year. In a very stable gastro-intestinal market. They're also in-licence some drugs which gives them some pretty good upside. Trading at about US$14 with $1 a share free cash on the balance sheet.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Chris Fernyc

Portfolio , Bissett Investment...

Price Price
$18.600
Owned Owned
Yes

TOP PICK
Axcan Pharmaceuticals(AXP-T) 

November 24, 2004

A very focused (gastro intestinal) pharmaceutical company and as a result, it is very profitable. You pretty well get a free call option on a potentially block-buster drug called Itax. Huge market in North America.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A very focused (gastro intestinal) pharmaceutical company and as a result, it is very profitable. You pretty well get a free call option on a potentially block-buster drug called Itax. Huge market in North America.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Fred Pynn

Portfolio , Bissett Investment M...

Price Price
$20.980
Owned Owned
Yes

TOP PICK
Axcan Pharmaceuticals(AXP-T) 

November 9, 2004

Last news was that R&D spending would be higher than the street anticipated. Launching a product that could be a $200 million product.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Last news was that R&D spending would be higher than the street anticipated. Launching a product that could be a $200 million product.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Danny Tomka

Portfolio , MFC Global Investmen...

Price Price
$19.500
Owned Owned
Yes

BUY
Axcan Pharmaceuticals(AXP-T) 

November 11, 2003

Has a very good ROE. Efficient balance sheet structure. Continuing to grow their earnings. Valuation is reasonable.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Has a very good ROE. Efficient balance sheet structure. Continuing to grow their earnings. Valuation is reasonable.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Arender,

Unknown, Unknown...

Price Price
$17.400
Owned Owned
Unknown

TOP PICK
Axcan Pharmaceuticals(AXP-T) 

November 3, 2003

The entire US financial sector is attractive. Their brokerage sector is growing rapidly. Expects travel business will pick up.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
The entire US financial sector is attractive. Their brokerage sector is growing rapidly. Expects travel business will pick up.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
John Sinkins, C

Senior Por, Sentry Select Capita...

Price Price
$47.230
Owned Owned
Yes

DON'T BUY
Its OK earnings wise. They are trying to make a hostile take over which looks expensive. Core business is OK.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Its OK earnings wise. They are trying to make a hostile take over which looks expensive. Core business is OK.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Glenn Paradis,

Vice Presi, Aegon Capital Manage...

Price Price
$16.930
Owned Owned
Unknown

BUY
Axcan Pharmaceuticals(AXP-T) 

January 20, 2003

A good long term hold. They focus on their earnings. Well managed.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A good long term hold. They focus on their earnings. Well managed.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Pierre Bernard

Vice Presi, Industrial Alliance ...

Price Price
$17.850
Owned Owned
Unknown

DON'T BUY
Axcan Pharmaceuticals(AXP-T) 

January 31, 2002

Had a nice run. May be a bit high now.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Had a nice run. May be a bit high now.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Malvin Spooner

Chairman a, Mavrix Fund Manageme...

Price Price
$21.500
Owned Owned
Unknown

STRONG BUY
Axcan Pharmaceuticals(AXP-T) 

December 11, 2000

Products selling very well. Sales force based in US
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Products selling very well. Sales force based in US
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Ed Ho

Portfolio , Dynamic Mutual Funds...

Price Price
$14.950
Owned Owned
Unknown

Showing 1 to 9 of 9 entries
Successfully Saved Company
Successfully Saved Company